| Milton hoop player battling off the court
When the Milton High School varsity basketball players received their uniforms this week, one team member received his jersey while in a hospital room at Fletcher Allen Health Care.
Head coach Chris Brown cancelled practice Wednesday so the team could be present when Jeffrey Cota Jr. received the blue and white No. 7 jersey. Cota, 17, has been diagnosed with osteosarcoma, a rare bone cancer that is expected to sideline him for the season. He underwent his fourth round of chemotherapy this week.
Cota is expected to have surgery to have most of his left femur replaced and an artificial knee implanted, according to his mother, Becky Cota. The surgery is tentatively set for January in Boston.
The community has rallied around the Cota family, who live in the town of Georgia.
World’s Largest Clinical Trial Into Rare Bone Cancer ‘Well ...
The worlds largest study aimed at improving the treatment of a rare type of bone cancer that mainly affects children and young adults is well underway, an international conference was told. The EURAMOS clinical trial, which involves a collaboration across 11 European countries, as well as the US and Canada, is on course to recruit some 1400 patients over the next few years to improve treatment for osteosarcoma, the most common bone cancer in children.
.
Friend with cancer lives on through her gift of locks of love
Locks of love the long, healthy hair of people, grown so beauticians can cut at least 10 inches to put in a plastic bag and send to the Locks of Love program to make into wigs for children who have lost their own to cancer treatments. My friend Nancy Williams Holden grew her hair long enough last year to send it to a child. She had to wait until her own treatments for bone cancer were over for a while, so it would be a good, full, healthy head of hair. And boy, was it dark, long and shiny. I know the child who receives this hair will be thrilled. When Nancy first became ill four years ago, doctors said cancer would take her life in two months. At the time, she had a 12-year-old son, Judah. She wasn't ready to leave him, her husband, John, nor her supportive mom and dad, Pete and Helen Williams.
REASON TO BELIEVESPECIAL STORIES FOR THE HOLIDAYS: Helping others heal, she heals herself
Shelly Glaspell was in her mid-20s, had two young sons and was engaged to be married when she felt the pain in her shoulder. Doctors suggested a pulled muscle or torn rotator cuff, her mother said, and several times over several months prescribed anti-inflammatory medicine. The pain persisted. It wasn't until nearly half a year later, in March 2001, that an MRI revealed what was wrong. Shelly had a rare bone cancer, Ewing's Sarcoma, which usually affects children during puberty. Shelly was sure she could beat it. She moved up her wedding date and began chemotherapy the day after the ceremony. After three months of treatments and surgery to remove her shoulder blade, her mother said doctors found no evidence of cancer.
Springbok Sevens bravest fan
Robert Louw is a regular teenager. He is passionate about rugby, enjoys horse-riding, loves chatting up the girls and is thrilled to be attending York High School in 2007. However life has not always been so easy for Robert. In 1995 at the age of 22 months, Robert was diagnosed with Rhabdomysosarcoma, a rare type of bone cancer which originates in the soft tissue of the bone. Intensive radiotherapy and radiation treatment followed, and for a period of six years after treatment Robert continued to have regular scans and x-rays. The good news is that since his treatment in 1995, Robert has been in remission ever since and now at the tender age of thirteen, Roberts greatest dream has become a reality. Robert was overjoyed to be selected by The Reach for a Dream Foundation to attend a private breakfast with the Springbok Sevens on Thursday 7 December at the Protea Wilderness Hotel.
Community Cancer Center -- Let's grab opportunity
I had been out of the nest for several years before my mother was diagnosed with Lymphoma. It started as a small lump on the side of her neck and then masses were found throughout her body. The diagnosis was not good and, with aggressive treatments, the doctors predicted a life expectancy of two to five years. Obviously, the news stunned our family. My mother was a very strong-willed woman, but how could she possibly fight this angry invader? I can only imagine how difficult this would be to deal with if I had been a child still needing a mother to direct my life. I recall the day my best friend's mother died from bone cancer when he was just 16 years of age. The trauma he experienced probably played a role in the direction his life took, which was not the path many of us would willingly choose.
Consultant Ferguson facing cancer again
ANAHEIM - The Sharks were stunned to learn over the weekend that special consultant John Ferguson was given a diagnosis of cancer for a second time. Ferguson, who beat prostate cancer in 2005, is undergoing radiation treatments in Toronto for bone cancer. ``Fergie has a challenge ahead of him,'' General Manager Doug Wilson said. ``We think about him every day, and he has the support and thoughts of everyone in the organization throughout this fight.'' Ferguson was unable to attend the number retirement ceremony of his friend Serge Savard in Montreal on Saturday. Many were puzzled by his absence, but none knew of Ferguson's medical situation at the time. • The Sharks activated forward Mark Smith (charley horse) from injured reserve Tuesday, but he sat out for the third consecutive game.
World's Largest Clinical Trial Into Rare Bone Cancer 'well ...
The world's largest study aimed at improving the treatment of a rare type of bone cancer that mainly affects children and young adults is well underway, an international conference was told.
The EURAMOS clinical trial, which involves a collaboration across 11 European countries, as well as the US and Canada, is on course to recruit some 1400 patients over the next few years to improve treatment for osteosarcoma, the most common bone cancer in children.
Doctors and scientists meeting at a conference in Stuttgart, Germany last week heard that recruitment for the trial was on track, with some 335 patients so far being treated within the trial.
The conference, - Pan European Sarcoma Trials - moving forward in a climate of increasing economic and regulatory pressure', represented a unique gathering of experts in the field of the type of cancer called sarcomas.
|
